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Objective: To determine the prevalence of Covid-19 in the district of Gujrat, its association with gender, age, its 
correlation with respiratory and cardiac symptoms and to find the link of this disease with travel history of 
patients to affected areas. 
Methodology: A total of 222 COVID-19 -Positive patients (Male and Female) out of 514 clinically suspected cases 
(fever, cough, dyspnoea, lethargy & anosmia) as per WHO guidelines were selected. The use of the data for 
research purposes was explained to patients and informed consent was taken. The study was approved by the 
ethical committee of Aziz Bhatti Shaheed Hospital. Samples were extracted from nasopharyngeal swabs using 
standard extraction protocol. Statistical tools used was SPSS Version 24. Chi-square test and correlation of age 
with respiratory and cardiac symptoms was calculated. 
Results: Male gender was significantly affected by this disease (P=0.001) as compared to the female gender. 
Regarding the prevalence of respiratory symptoms, 31(14%) were asymptomatic. 37(16.7%) had Dyspnea, 45 
(65.3%) cough (P= 0.001). Nine (4.1%) developed pneumonia. Fever and Cough was the most common symptom 
in the age group 21-40 yrs(P=0.001). While pneumonia developed in the older age group. The cardiac symptoms 
appeared in young age group (p=0.000) in the age group 21-40 yrs (70.9% n=78).38 patients (17.2%) had the 
symptom of chest pain, 24(10.9%) tachycardia and 1(0.5%) developed arrhythmia. Out of 222 COVID positive 
patients, 67.1% (149) gave a history of direct contact with positive patients, 19.8% (n=44) gave travel history,4.5% 
(n=10) had a history of going to Raiwind Ijtamah and 8.6% (n=19) were zaireen/pilgrims from Taftan. 
Conclusion: The COVID -19 is comparatively more common in male patients. 50% of the patients were of age 
group 21-40 years showing the symptoms of fever and cough along with mild cardiac symptoms. Acute 
pneumonia developed in older age groups while cardiac symptoms were significant in young age. In Gujrat 
District, the majority of the patients (67.1%) developed Covid-19 due to travelling.  
Keywords: Age, Covid-19, Gender, Patients, Prevalence,  Travel. 




Severe Acute Respiratory Syndrome Corona virus-2 
(SARS-Cov-2) rapidly spread and led to an outbreak in 
China and then became a global health emergency. 
Today globally confirmed cases are incredibly high. 
Through the week ending 2 August, 17.6 million 
confirmed Covid-19 cases, including more than 680 
000 deaths have been reported to WHO. In Pakistan 
confirmed cases are 280 029 and total deaths reported 
are 17190.1 Although control preventive measures 
used was the isolation of the patients, the infection has 
increased and became a pandemic.2 The first case of 
pneumonia emerged in the city of Wuhan, Hubei 
Province, China, in early December 2019. From these 
patients, a novel coronavirus had been isolated, and 
subsequently, it was named as 2019 novel coronavirus 
(2019-nCoV) on January 12, 2020and later as SARS-
CoV-2. This disease was mostly associated with 
Human Seafood, but soon the disease spread rapidly 
to other areas of the country. On January 19, 2020, two 
cases in Beijing and one case in Guangdong Province 
were reported, and subsequently more cases were 
reported elsewhere.3 
This is a viral respiratory infection, SARS-CoV-2 or 
COVID-19 can be transmitted through the respiratory 
tract. It mainly causes respiratory tract infections and 
develops severe pneumonia in infected patients. The 
disease may progress to respiratory failure and death. 
Everyone is at risk of catching this infection, but the 
elderly and those with underlying diseases are more 
susceptible and are at risk of adverse outcomes.2The 
virus main entranceway is through mucosal tissues of 
the nose, mouth, upper respiratory tract, and 
conjunctival mucosa.4 In hospitalized patients, it was 
found that the onset of COVID-19 is associated with 
symptoms commonly associated with viral 
pneumonia, most commonly fever, cough and 
myalgia.5 
According to the WHO/China Report, 80% of cases in 
China up to 20 February 2020 have a mild-to-moderate 
disease which includes both pneumonia and non- 
pneumonia cases; whilst 13.8% developed severe 
disease and 6.1% progressed to a critical stage and 
needed intensive care. In a study of clinical 
progression in 1,099 patients, it was found that people 
over the age of 60 years and those with underlying 
conditions (hypertension, cardiovascular disease, 
diabetes and chronic respiratory disease) were more at 
risk.6 Through hospital surveillance symptoms like 
atypical pneumonia and/or acute respiratory distress 
were used to define suspected cases eligible for 
testing. Emerging evidence from China suggests that 
coronavirus disease 2019 (COVID-19) is deadlier for 
infected men than women with a 2.8% fatality rate 
being reported in Chinese men versus 1.7% in women. 
Further, sex-disaggregated data for COVID-19 in 
several European countries show a similar number of 
cases between the sexes, but more severe outcomes in 
aged men.7  
The combination of symptoms (e.g. cough and fever)  
with recent travel history to the affected region 
(Wuhan and/or Hubei Province)was found to be a 
source of spread of infection.8,9 Such surveillance is 
therefore likely to detect clinically milder cases but, by 
initially restricting testing to those with a travel 
history or link, may have missed other symptomatic 
cases. More recently, as epidemics have taken off in 
other countries, cases are now being detected in those 
with no reported travel links to Wuhan/Hubei 
province through broader surveillance systems.10 
The border countries of Pakistan highly affected 
including China, where the COVID-19 outbreak 
experienced the first time. In the west, Italy with the 
highest number of COVID-19 mortalities while in the 
north, Iran a high number of mortalities after Italy. 
Initially, all of the confirmed cases had recent travel 
history from Iran, Syria and London. And currently, 
these cases increase by high rate and the situation is 
worst.11 
In contrast, others will represent the severe end of the 
disease spectrum with an increasing number 
identified through hospital surveillance (for example, 
testing of viral pneumonia) or in a few cases, at post-
mortem analysis.6 
The study aims to find the prevalence of this disease 
and its association with risk to the gender, the 
common symptoms presented by the cases and link to 




This Cross-sectional Study was carried out in the Aziz 
Bhatti Shaheed Hospital affiliated with Nawaz Sharif 
Medical College, University Of Gujrat, Pakistan. Study 
duration was 01 months.  
All patients were between 15  and 80 years visiting the 
hospital from 7th April to 15th May 2020. The total 
sample size was 514. 
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Inclusion criteria were patients admitted with COVID 
19 symptoms, had laboratory-confirmed SARS-COV 2 
infection as determined by PCR test, illness of any 
duration and on of following: Radiographic Infiltrates 
by imaging ( chest x-ray, CT Scan), OR clinical 
assessment ( evidence rales/crackles on the exam) and 
SPO2 less than 94% on room air, Requiring 
supplementing oxygen or Requiring mechanical 
ventilation.  
The study protocol was approved by the Ethics 
Committee of Aziz Bhatti Shaheed Hospital, Gujrat, 
Province Punjab. The population of Gujrat is 2,756,110, 
covering an area of 3,192 km2. Out of 514 cases, 222 
cases meeting the inclusion criteria were selected. 
Consecutive Non-Random sampling technique was 
used. The assumption for sample calculation is that it 
is a single centred study. We selected all the patients 
that came to our centre.  
RNA samples were extracted from nasopharyngeal 
swabs secretions using standard extraction protocol. 
The tests were performed in the molecular biology lab. 
Laboratory had DNA free equipment with negative 
pressure known as BIOSAFETY LEVEL 3 Lab. 
WHO sample size calculator was used to find out the 
sample size. Data was entered and analyzed in the 
statistical package for social sciences Version 24. Chi-
square test was applied to calculate the significance of 
qualitative variables. Spearman correlation was 
calculated to find an association between age and 





Males were highly significantly suffering from this 
disease (P=0.001) (Table-1) as compared to females 
who are usually non-working in our society and 
remain indoors and lesser exposed to a person to 
person contact and interaction. Age is significantly 
associated with gender (P=0.001) (Figure 1). Female 
patients who had this disease gave a history of the 
same infection to the male members of the family. The 
number of males was 159 (71.6%) and females 63 
(28.4%). The 50% of patients (n=111) were seen in the 
age group 21-40 years and 22.1% (n=49) were found in 
the age group 41-60 years.76.6% males and 23.4% of 
females were found in the age group 21-40 years 
(Figure 1). 
 
Figure 1: Distribution of male and female in Patients 

































59                                                                 Journal of Rawalpindi Medical College (JRMC); 2020; 24 Supplement-1: 56-62 
Table 1: COVID-19 Positive patients of different age groups presenting with respiratory symptoms 
 Respiratory symptoms Total Chi-square test 
nil Dyspnoea Cough Pneumonia 
Age 15 - 20 14 0 23 0 37  
21-40 17 34 60 0 111  
41-60 0 3 40 6 49 P=0.000 
61-80 0 0 22 3 25  
Total 31 37 145 9 222  
 
Regarding the prevalence of respiratory symptoms, 31(14%) were asymptomatic. 37(16.7%) had Dyspnea, 45 
(65.3%) cough P= 0.001 and 9 (4.1%) developed pneumonia. The cough was the most common symptom in the 
age group 21-40 years(P=0.001) while pneumonia developed in older age group (61-80 years). A possible reason 
for the development of pneumonia in this age group could be decreased immunity in this age group. 
Out of 221 cases 71.5%(n=158) had no cardiac symptoms(P=0.001).Most of these were found in age group 21-40 
years (70.9% n=78) (P=0.000). 
38 people (17.2%) had a symptom of chest pain, 24(10.9%) tachycardia and 1(0.5%) developed arrhythmia. Two 
patients (male) died due to the development of complications (Pneumonia and myocarditis). 
Correlation between age and respiratory symptoms (Table 2) show a positive correlation. As age increases there is 
also increase in severity of symptoms such as pneumonia. 
 
Table 2: Covid-19 Positive patients of different age groups presenting with cardiac symptoms 




Age 15 - 20 17 11 8 1 37  
21-40 78 16 16 0 111 P=0.000 
41-60 45 4 0 0 49  
61-80 18 7 0 0 25  
Total 158 38 24 1 222  
 
On contrary cardiac symptoms are negatively correlated. Young people developed more cardiac symptoms 
(Table 3) as compared to old patients. 
Table 3: Correlation matrix showing the Spearman’s correlation coefficient (rs) for age groups with respiratory 
and cardiac symptoms 




Spearman's rho age of participants Correlation Coefficient rs 1.000 -.272** 
Sig. (2-tailed) p  .000 
N 222 222 
 age of participants Correlation Coefficient rs 
Sig. (2-tailed) p 
1.000 .400** 
          .000 
 
Out of 222 patients, 67.1% (149) gave a history of direct contact with positive patients, 19.8% (n=44) gave travel 
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Coronavirus is defined as a family of viruses which 
cause illness which ranges from the common cold to 
acute pneumonia, such as SARS 10 and Middle East 
Respiratory Syndrome (MERS).11 The Chinese Centre 
for Disease Control and Prevention (CDC) identified 
SARS-CoV-2.13 Epidemiological 14,15 and clinical 16,17 
features of patients suffering from Covid-19 have been 
reported. However, prognostic factors of Covid-19 are 
yet to be reported in detail. In our study, males were 
suffering from the disease in greater significance 
(P=0.001) as compared to females who are usually 
non-working in our society and remain indoors and 
lesser exposure to a person to person contact and 
interaction. The females who were COVID-19 positive 
gave a history of the same infection to the male 
members of the family. Hence, the number of males 
was 159 (71.6%) and the number of females was 63 
(28.4%). 50% of the patients (n=111) were seen in the 
age group of 21-40 yrs and 22.1% (n=49) were found in 
the age group of 41-60 yrs. 
Older patients (65 yrs old and above) were more likely 
to suffer from severe COVID-19. Men tend to develop 
more serious symptoms than women, according to the 
clinical classification of severity. According to public 
data set of COVID-19, it was found that the % of older 
age (65 yrs and above) was much higher in patients 
who were deceased than in the patients who survived 
(83.8% in 37 patients deceased vs 13.2% in 1019 
patients who survived). Additionally, the number of 
men in deceased patients is 2.4 times that of women. 
Although men and women have the same 
susceptibility, men are conclusively more prone to 
dying.18 
 This study investigated the role of gender in the 
morbidity and mortality of the SARS-CoV-2 infection. 
One study of which consisted of 425 patients with 
COVID-19 indicated that 56% of them were males.14 
While another study of 140 patients established that 
50.7% were males.18 In another similar study, 
susceptibility to SARS-CoV-2 was observed between 
males and females in 1,019 patients who survived 
(50.0% males), collected from a public data set and in a 
case series of 43 patients who were hospitalized (51.2% 
males). Although deceased patients were solder than 
the patients who had survived COVID-19, ages were 
comparable for males and females in both deceased as 
well as patients who survived. Therefore, it can be 
established that gender is a risk factor for high severity 
and mortality in patients suffering from COVID-19, 
regardless of age and susceptibility.19 
The gender factor, as well as high incidence rate in 
men for most diseases, could correlate with the 
general demographic fact of shorter life expectancy in 
men when compared to women in the world. 
Although there seems to be no notable difference in 
median age amongst male and female groups, the 
maximum range of IQR is lower in males in case 
series. In 2003, the data collected from a population of 
520 SARS patients which included 135 deaths in 
Beijing20 summarised the lessons for present use, as 
SARS-CoV-2 and SARS-CoV attack tissue cells via the 
same receptor i.e. ACE2.21 We have reported that high 
protein expression of receptor ACE2 in specific organs 
correlated with particular organ failures, as indicated 
by corresponding parameters in SARS patients.20,22 It 
has been observed that the circulating ACE2 levels are 
greater in men than in women as well as in patients 
with diabetes and/or cardiovascular diseases23 leading 
to greater morbidity and mortality in patients 
suffering from COVID-19. Men with COVID-19 are at 
higher risk for worse outcomes including death, 
regardless of age.19 
Out of 222 cases, 71.5% (n =158) of the cases had no 
cardiac symptoms (P=0.001). Majority of these were 
found in the age group of 21-40 years (70.9% n=78) 
P=0.000.38 people (17.2%) displayed symptoms of 
chest pain, 24 (10.9%) showed tachycardia and 1 
(0.5%) had developed arrhythmia. 
Regarding the prevalence of respiratory symptoms, 31 
(14%) were asymptomatic. 37 (16.7%) developed 
dyspnea, 45 (65.3%) developed cough P= 0.001 and 9 
(4.1%) had developed pneumonia. The cough was the 
most prevalent symptom in the age group of 21-40 
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years (P=0.001) while pneumonia had developed in 
the older age group of (61-80 years). A probable reason 
for the development of pneumonia in this specific age 
group could be the decreased immunity with an 
increase in age. 
From Jan 21, 2019, when the first case of Covid-19 was 
identified, up to Feb 15, 2020, in a study based on 2123 
patients in Fever Clinic, due to fever and/or 
respiratory symptoms, 342 of the patients were 
confirmed to have developed pneumonia by CT scan, 
or in some cases by chest x-ray. The presence of 
COVID-19 in pneumonia patients was 6.14% (21/342). 
Whereas the presence of COVID-19 in cases that had 
developed pneumonia sent for 2019-nCoV testing, was 
at 23.9% (21/88).24 
The data collected from China depicts a radical 
increase in the number of cases of pneumonia with an 
increase in age. Our results, however, suggest a very 
low fatality ratio in those who are under the age of 20. 
Albeit, as there are very few noted cases in this age 
group, it remains to be seen whether this reflects a low 
mortality rate or a difference in susceptibility. 
Therefore, serological testing in this age group can 
prove to be critical in the coming weeks to understand 
the importance and significance of this age group in 
driving population transmission of the disease. There 
is a transparent rise in the estimated CFR from the age 
of 50 and upwards, with the proportion rising from 
approximately 1% in the age group of 50-59 to 13% in 
those who are aged 80 and above. The increase in 
severity with an increase in age is reflected in case 
reports in whom the mean age usually is in the range 
of 50 to 60 years. Different surveillance systems ought 
to pick up a different age-case-mix and we discovered 
that those displaying milder symptoms detected 
through the history of travelling are younger on 
average than those who were detected through 
hospital surveillance.25 
According to a study of 150 patients from 2 hospitals 
in Wuhan, China, shock seemed to be a significant 
reason for death in 40% of patients and may be 
associated with fulminant myocarditis. Further studies 
on risk factors associated with shock in patients who 
are COVID-19 are lacking. Varying majority of 
available studies seem to report unadjusted estimates. 
Despite methodological restrictions and limitations, 
studies suggest that old age, low lymphocyte count, 
comorbidities (diabetes in particular along with 
cardiovascular disease including hypertension), high 
D-dimer level, and cardiac injury are important risk 
factors that need to be considered.26 
Out of the 222 COVID-19 positive patients, 67.1% (149) 
patients gave a history of direct contact with positive 
patients, whereas 19.8% (n=44) gave travel history, 
and 4.5% (n=10) had a history of going to Raiwind 





The disease is more prevalent in men rather than 
women. 50% of the patients were of age group 21-40 
years showing the symptoms of fever and cough along 
with mild cardiac symptoms. Complications like acute 
pneumonia developed in older age groups, while 
cardiac symptoms were more commonly seen in 
young patients. In Gujrat, majority of the patients 
(67.1%) developed COVID-19 due to travelling to 
other vicinities. 
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